Can treatment-based HIV prevention curb the epidemic among gay and other men who have sex with men? A narrative synthesis of increasing evidence for moderating and countervailing effects
John B. F. de Wit A B C and Philippe C. G. Adam A
+ Author Affiliations
- Author Affiliations
A Centre for Social Research in Health, The University of New South Wales, Sydney, NSW 2052, Australia.
B Department of Social and Organisational Psychology, Utrecht University, PO BOX 80140, 3508 TC Utrecht, The Netherlands.
C Corresponding author. Email: j.dewit@unsw.edu.au
Sexual Health 11(2) 137-145 https://doi.org/10.1071/SH13142
Submitted: 15 September 2013 Accepted: 13 January 2014 Published: 12 March 2014
Abstract
As HIV epidemics among gay and other men who have sex with men (GMSM) persist worldwide, the importance of novel prevention approaches is recognised. Evidence that antiretroviral therapy (ART) can decrease the likelihood of infection is informing emerging HIV prevention approaches, encompassing early initiation of treatment as prevention by people living with HIV and use of antiretroviral drugs as pre-exposure prophylaxis for people presumed to be uninfected. Despite widespread excitement, robust evidence of the beneficial effects of ART-based HIV prevention for GMSM remains limited. Also, theoretical models project widely varying effects of ART-based prevention on the future course of HIV epidemics among GMSM, drawing attention to the possible moderating role of differences in the achievements of local HIV responses and the critical importance of sustained protective sexual practices into the future. Ecological analyses and simulations of ongoing epidemics in major gay communities illustrate that the preventive effects of ART in many settings are being offset by increased sexual risk-taking, as reflected in stable or increasing HIV infection rates. Also, the effects of scaling up HIV testing and treatment among GMSM in settings that are often considered prime examples of the success of ART-based prevention may be levelling as ‘scope for improvement’ diminishes. ART-based approaches further extend the HIV prevention toolkit and substantially increase people’s options to protect themselves and others. The future impact of ART-based prevention on HIV epidemics among GMSM ultimately depends on whether heralded responses offset, attenuate or compound the ongoing social and behavioural changes that drive increased sexual risk.
Additional keywords: antiretroviral therapy, biobehavioural interventions, combination prevention, prevention revolution, risk compensation, treatment-as-prevention.
References
[1] Joint United Nations Programme on HIV/AIDS (UNAIDS). Global report: UNAIDS report on the global AIDS epidemic 2012. Geneva: UNAIDS; 2012. Available online at: http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2012/gr2012/20121120_UNAIDS_Global_Report_2012_en.pdf [verified August 2013].[2] Beyrer C, Abdool Karim Q. The changing epidemiology of HIV in 2013. Curr Opin HIV AIDS 2013; 8 306–10.
| 23743721PubMed |
[3] Beyrer C, Baral SD, van Griensven F, Goodreau SM, Chariyalertsak S, Wirtz AL, et al Global epidemiology of HIV infection in men who have sex with men. Lancet 2012; 380 367–77.
| Global epidemiology of HIV infection in men who have sex with men.Crossref | GoogleScholarGoogle Scholar | 22819660PubMed |
[4] Beyrer C, Sullivan P, Sanchez J, Baral SD, Collins C, Wirtz AL, et al The global HIV epidemics in MSM: time to act. AIDS 2013; 27(17): 2665–2678.
| The global HIV epidemics in MSM: time to act.Crossref | GoogleScholarGoogle Scholar | 23902921PubMed |
[5] Havlir D, Beyrer C. The beginning of the end of AIDS? N Engl J Med 2012; 367 685–7.
| The beginning of the end of AIDS?Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC38XhtlSlt77E&md5=03eaedbd08abe81004d4b2850bb1d7d7CAS | 22809362PubMed |
[6] Sullivan PS, Carballo-Diéguez A, Coates T, Goodreau SM, McGowan I, Sanders EJ, et al Successes and challenges of HIV prevention in men who have sex with men. Lancet 2012; 380 388–99.
| Successes and challenges of HIV prevention in men who have sex with men.Crossref | GoogleScholarGoogle Scholar | 22819659PubMed |
[7] Adam PCG, de Wit JBF, Toskin I, Mathers BM, Nashkhoev M, Zablotska I, et al Estimating levels of HIV testing, HIV prevention coverage, HIV knowledge, and condom use among men who have sex with men (MSM) in low-income and middle-income countries. J Acquir Immune Defic Syndr 2009; 52 S143–51.
| Estimating levels of HIV testing, HIV prevention coverage, HIV knowledge, and condom use among men who have sex with men (MSM) in low-income and middle-income countries.Crossref | GoogleScholarGoogle Scholar |
[8] Baral S, Sifakis F, Cleghorn F, Beyrer C. Elevated risk for HIV infection among men who have sex with men in low- and middle-income countries 2000–2006: a systematic review. PLoS Med 2007; 4 e339
| Elevated risk for HIV infection among men who have sex with men in low- and middle-income countries 2000–2006: a systematic review.Crossref | GoogleScholarGoogle Scholar | 18052602PubMed |
[9] Kirby Institute. HIV, viral hepatitis and sexually transmissible infections in Australia annual surveillance report 2012. Sydney: Kirby Institute, University of New South Wales; 2013.
[10] Commission on AIDS in Asia. Redefining AIDS in Asia: crafting an effective response. New Delhi: Oxford University Press; 2008.
[11] Zhang M, Chu Z, Wang H, Xu J, Lu C, Shang H. A rapidly increasing incidence of HIV and syphilis among men who have sex with men in a major city of China. AIDS Res Hum Retroviruses 2011; 27 1139–40.
| A rapidly increasing incidence of HIV and syphilis among men who have sex with men in a major city of China.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3MXhs1ShsbbP&md5=e77a5f63308501cdd462738e6cd1be56CAS | 21388334PubMed |
[12] van Griensven F, Thienkrua W, McNicholl J, Wimonsate W, Chaikummao S, Chonwattana W, et al Evidence of an explosive epidemic of HIV infection in a cohort of men who have sex with men in Bangkok, Thailand. AIDS 2013; 27 825–32.
| Evidence of an explosive epidemic of HIV infection in a cohort of men who have sex with men in Bangkok, Thailand.Crossref | GoogleScholarGoogle Scholar | 23169330PubMed |
[13] Beyrer C, Sullivan PS, Sanchez J, Dowdy D, Altman D, Trapence G, et al A call to action for comprehensive HIV services for men who have sex with men. Lancet 2012; 380 424–38.
| A call to action for comprehensive HIV services for men who have sex with men.Crossref | GoogleScholarGoogle Scholar | 22819663PubMed |
[14] Hankins C. Overview of the current state of the epidemic. Curr HIV/AIDS Rep 2013; 10 113–23.
| Overview of the current state of the epidemic.Crossref | GoogleScholarGoogle Scholar | 23579359PubMed |
[15] Sullivan PS, Hamouda O, Delpech V, Geduld JE, Prejean J, Semaille C, et al Reemergence of the HIV epidemic among men who have sex with men in North America, Western Europe, and Australia, 1996–2005. Ann Epidemiol 2009; 19 423–31.
| Reemergence of the HIV epidemic among men who have sex with men in North America, Western Europe, and Australia, 1996–2005.Crossref | GoogleScholarGoogle Scholar | 19460672PubMed |
[16] Rausch DM, Grossman CI, Erbelding EJ. Integrating behavioral and biomedical research in HIV interventions: challenges and opportunities. J Acquir Immune Defic Syndr 2013; 63 S6–11.
| Integrating behavioral and biomedical research in HIV interventions: challenges and opportunities.Crossref | GoogleScholarGoogle Scholar | 23673890PubMed |
[17] Warren MJ, Bass ES. Perspectives on HIV prevention: priorities for a new era. J Acquir Immune Defic Syndr 2013; 63 S255–9.
| Perspectives on HIV prevention: priorities for a new era.Crossref | GoogleScholarGoogle Scholar | 23764644PubMed |
[18] Kippax S. Effective HIV prevention: the indispensable role of social science. J Int AIDS Soc 2012; 15 17357
| Effective HIV prevention: the indispensable role of social science.Crossref | GoogleScholarGoogle Scholar | 22713254PubMed |
[19] Mao L, Kippax SC, Holt M, Prestage GP, Zablotska IB, de Wit JB. Rates of condom and non-condom-based anal intercourse practices among homosexually active men in Australia: deliberate HIV risk reduction? Sex Transm Infect 2011; 87 489–93.
| Rates of condom and non-condom-based anal intercourse practices among homosexually active men in Australia: deliberate HIV risk reduction?Crossref | GoogleScholarGoogle Scholar | 21764890PubMed |
[20] Vergidis PI, Falagas ME, Hamer DH. Meta-analytical studies on the epidemiology, prevention, and treatment of human immunodeficiency virus infection. Infect Dis Clin North Am 2009; 23 295–308.
| Meta-analytical studies on the epidemiology, prevention, and treatment of human immunodeficiency virus infection.Crossref | GoogleScholarGoogle Scholar | 19393910PubMed |
[21] Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, et al Viral load and heterosexual transmission of human immunodeficiency virus type 1. N Engl J Med 2000; 342 921–9.
| Viral load and heterosexual transmission of human immunodeficiency virus type 1.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD3c7otlWjsA%3D%3D&md5=840bfc6a59a802b5a92fc2aebae7ff2dCAS | 10738050PubMed |
[22] Hosseinipour M, Cohen MS, Vernazza PL, Kashuba AD. Can antiretroviral therapy be used to prevent sexual transmission of human immunodeficiency virus type 1? Clin Infect Dis 2002; 34 1391–5.
| Can antiretroviral therapy be used to prevent sexual transmission of human immunodeficiency virus type 1?Crossref | GoogleScholarGoogle Scholar | 11981736PubMed |
[23] Cohen MS, Gay C, Kashuba ADM, Blower S, Paxton L. Narrative review: antiretroviral therapy to prevent the sexual transmission of HIV-1. Ann Intern Med 2007; 146 591–601.
| Narrative review: antiretroviral therapy to prevent the sexual transmission of HIV-1.Crossref | GoogleScholarGoogle Scholar | 17438318PubMed |
[24] Montaner JS, Hogg R, Wood E, Kerr T, Tyndall M, Levy AR, et al The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. Lancet 2006; 368 531–6.
| The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic.Crossref | GoogleScholarGoogle Scholar | 16890841PubMed |
[25] Muessig KE, Smith MK, Powers KA, Lo YR, Burns DN, Grulich AE, et al Does ART prevent HIV transmission among MSM? AIDS 2012; 26 2267–73.
| Does ART prevent HIV transmission among MSM?Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC38Xhs12is77O&md5=908da9fa904292b9dabb49d79ed0698aCAS | 22569019PubMed |
[26] Youle M, Wainberg MA. Could chemoprophylaxis be used as an HIV prevention strategy while we wait for an effective vaccine? AIDS 2003; 17 937–8.
| Could chemoprophylaxis be used as an HIV prevention strategy while we wait for an effective vaccine?Crossref | GoogleScholarGoogle Scholar | 12660549PubMed |
[27] Rey D. Post-exposure prophylaxis for HIV infection. Expert Rev Anti Infect Ther 2011; 9 431–42.
| Post-exposure prophylaxis for HIV infection.Crossref | GoogleScholarGoogle Scholar | 21504400PubMed |
[28] Baeten JM, Haberer JE, Liu AY, Sista N. Preexposure prophylaxis for HIV prevention: where have we been and where are we going? J Acquir Immune Defic Syndr 2013; 63 S122–9.
| Preexposure prophylaxis for HIV prevention: where have we been and where are we going?Crossref | GoogleScholarGoogle Scholar | 23764623PubMed |
[29] Vernazza P, Hirschel B, Bernasconi E, Flepp M. Les personnes seropositives ne souffrant d’aucune autre MST et suivant un traitment antiretroviral efficace ne transmettent pas le VIH par voie sexuelle. Bull Med Suisses. 2008; 89 165–9.
[30] De Wit JBF, Adam PCG. Revolution or evolution? What can approaches based on the use of antiretroviral drugs contribute to HIV prevention in gay communities in high-income countries? In Eaton LA, Kalichman SC, editors. Biomedical advances in HIV prevention: social and behavioral perspectives. New York: Springer; 2013. pp. 181–204.
[31] Padian NS, McCoy SI, Karim SS, Hasen N, Kim J, Bartos M, et al HIV prevention transformed: the new prevention research agenda. Lancet 2011; 378 269–78.
| HIV prevention transformed: the new prevention research agenda.Crossref | GoogleScholarGoogle Scholar | 21763938PubMed |
[32] Padian NS, Isbell MT, Russell ES, Essex M. The future of HIV prevention. J Acquir Immune Defic Syndr 2012; 60 S22–6.
| The future of HIV prevention.Crossref | GoogleScholarGoogle Scholar | 22772385PubMed |
[33] Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, et al Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 2010; 329 1168–74.
| Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3cXhtV2hsr%2FI&md5=9a7a2e7f485b2de7636e6f7d564dd637CAS | 1:CAS:528:DC%2BC3cXhtV2hsr%2FI&md5=9a7a2e7f485b2de7636e6f7d564dd637CAS | 20643915PubMed |
[34] Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010; 363 2587–99.
| Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3MXit1ansg%3D%3D&md5=091a35e1d710da4786fd48a26de243edCAS | 1:CAS:528:DC%2BC3MXit1ansg%3D%3D&md5=091a35e1d710da4786fd48a26de243edCAS | 21091279PubMed |
[35] Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365 493–505.
| Prevention of HIV-1 infection with early antiretroviral therapy.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3MXhtVars7jF&md5=f28f0bc4d943ad7366817444e30a0eaeCAS | 1:CAS:528:DC%2BC3MXhtVars7jF&md5=f28f0bc4d943ad7366817444e30a0eaeCAS | 21767103PubMed |
[36] Thigpen MC, Kebaabetswe PM, Paxton LA, Smith DK, Rose CE, Segolodi TM, et al Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med 2012; 367 423–34.
| Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC38XhtlSltrbE&md5=36a3d557e6f39b7f4eb034c227f57ae8CAS | 1:CAS:528:DC%2BC38XhtlSltrbE&md5=36a3d557e6f39b7f4eb034c227f57ae8CAS | 22784038PubMed |
[37] Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, et al Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med 2012; 367 399–410.
| Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC38XhtlSltrbK&md5=a5af5fd342ef83c6f44d86a4b399fe7bCAS | 1:CAS:528:DC%2BC38XhtlSltrbK&md5=a5af5fd342ef83c6f44d86a4b399fe7bCAS | 22784037PubMed |
[38] Choopanya K, Martin M, Suntharasamai P, Sangkum U, Mock PA, Leethochawalit M, et al Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet 2013; 381 2083–90.
| Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial.Crossref | GoogleScholarGoogle Scholar | 23769234PubMed |
[39] Baeten J, Celum C. Systemic and topical drugs for the prevention of HIV infection: antiretroviral pre-exposure prophylaxis. Annu Rev Med 2013; 64 219–32.
| Systemic and topical drugs for the prevention of HIV infection: antiretroviral pre-exposure prophylaxis.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3sXjsFKltr4%3D&md5=06f11b2ec4fb2a5b6200a6833f893c9fCAS | 1:CAS:528:DC%2BC3sXjsFKltr4%3D&md5=06f11b2ec4fb2a5b6200a6833f893c9fCAS | 23020883PubMed |
[40] Van Damme L, Corneli A, Ahmed K, Agot K, Lombaard J, Kapiga S, et al Preexposure prophylaxis for HIV infection among African women. N Engl J Med 2012; 367 411–22.
| Preexposure prophylaxis for HIV infection among African women.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC38XhtlSltrbL&md5=5127c48533312944e1c77b248aa9734eCAS | 22784040PubMed |
[41] Marrazzo J, Ramjee G, Nair G, Palanee T, Mkhize B, Nakabiito C, et al. Pre-exposure prophylaxis for HIV in women: daily oral tenofovir, oral tenofovir/emtricitabine, or vaginal tenofovir gel in the VOICE Study (MTN 003). Abstract #26LB. Paper presented at the 20th Conference on Retroviruses and Opportunistic Infections; 2013 March 3–6; Atlanta, Georgia.
[42] van der Straten A, Van Damme L, Haberer JE, Bangsberg DR. Unraveling the divergent results of pre-exposure prophylaxis trials for HIV prevention. AIDS 2012; 26 F13–9.
| Unraveling the divergent results of pre-exposure prophylaxis trials for HIV prevention.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC38Xls1Sluro%3D&md5=df2a823dac45c9b72d1e65ddf33d0ea5CAS | 1:CAS:528:DC%2BC38Xls1Sluro%3D&md5=df2a823dac45c9b72d1e65ddf33d0ea5CAS | 22333749PubMed |
[43] Holt M. HIV pre-exposure prophylaxis and treatment as prevention: a review of awareness and acceptability among men who have sex with men in the Asia-Pacific region and the Americas. Sex Health 2014; 11 166–70.
| HIV pre-exposure prophylaxis and treatment as prevention: a review of awareness and acceptability among men who have sex with men in the Asia-Pacific region and the Americas.Crossref | GoogleScholarGoogle Scholar | 23866853PubMed |
[44] Hosek S, Siberry G, Bell M, Lally M, Kapogiannis B, Green K, et al The acceptability and feasibility of an HIV pre-exposure prophylaxis (PrEP) trial with young men who have sex with men (YMSM). J Acquir Immune Defic Syndr 2013; 62 447–56.
| The acceptability and feasibility of an HIV pre-exposure prophylaxis (PrEP) trial with young men who have sex with men (YMSM).Crossref | GoogleScholarGoogle Scholar | 24135734PubMed |
[45] Granich R, Crowley S, Vitoria M, Lo YR, Souteyrand Y, Dye C, et al Highly active antiretroviral treatment for the prevention of HIV transmission. J Int AIDS Soc 2010; 13 1
| Highly active antiretroviral treatment for the prevention of HIV transmission.Crossref | GoogleScholarGoogle Scholar | 20205768PubMed |
[46] Smith MK, Powers KA, Muessig KE, Miller WC, Cohen MS. HIV treatment as prevention: the utility and limitations of ecological observation. PLoS Med 2012; 9 e1001260
| HIV treatment as prevention: the utility and limitations of ecological observation.Crossref | GoogleScholarGoogle Scholar | 22802740PubMed |
[47] Blower SM, Gershengorn HB, Grant RM. A tale of two futures: HIV and antiretroviral therapy in San Francisco. Science 2000; 287 650–4.
| 1:CAS:528:DC%2BD3cXovVyisA%3D%3D&md5=d655d337e36f52d45c73d78f738064c2CAS |
| 1:CAS:528:DC%2BD3cXovVyisA%3D%3D&md5=d655d337e36f52d45c73d78f738064c2CAS | 10649998PubMed |
[48] Charlebois ED, Das M, Porco TC, Havlir DV. The effect of expanded antiretroviral treatment strategies on the HIV epidemic among men who have sex with men in San Francisco. Clin Infect Dis 2011; 52 1046–9.
| The effect of expanded antiretroviral treatment strategies on the HIV epidemic among men who have sex with men in San Francisco.Crossref | GoogleScholarGoogle Scholar | 21460322PubMed |
[49] Desai K, Sansom SL, Ackers ML, Stewart SR, Hall HI, Hu DJ, et al Modeling the impact of HIV chemoprophylaxis strategies among men who have sex with men in the United States: HIV infections prevented and cost-effectiveness. AIDS 2008; 22 1829–39.
| Modeling the impact of HIV chemoprophylaxis strategies among men who have sex with men in the United States: HIV infections prevented and cost-effectiveness.Crossref | GoogleScholarGoogle Scholar | 18753932PubMed |
[50] Koppenhaver RT, Sorensen SW, Farnham PG, Sansom SL. The cost-effectiveness of pre-exposure prophylaxis in men who have sex with men in the United States: an epidemic model. J Acquir Immune Defic Syndr 2011; 58 e51–2.
| The cost-effectiveness of pre-exposure prophylaxis in men who have sex with men in the United States: an epidemic model.Crossref | GoogleScholarGoogle Scholar | 21921730PubMed |
[51] Sorensen SW, Sansom SL, Brooks JT, Marks G, Begier EM, Buchacz K, et al A mathematical model of comprehensive test-and-treat services and HIV incidence among men who have sex with men in the United States. PLoS ONE 2012; 7 e29098
| A mathematical model of comprehensive test-and-treat services and HIV incidence among men who have sex with men in the United States.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC38XivVKjsLc%3D&md5=a02d6673e085b66f1cd978e7cfeeae03CAS | 1:CAS:528:DC%2BC38XivVKjsLc%3D&md5=a02d6673e085b66f1cd978e7cfeeae03CAS | 22347994PubMed |
[52] Paltiel AD, Freedberg KA, Scott CA, Schackman BR, Losina E, Wang B, et al HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectiveness. Clin Infect Dis 2009; 48 806–15.
| HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectiveness.Crossref | GoogleScholarGoogle Scholar | 19193111PubMed |
[53] Juusola JL, Brandeau ML, Owens DK, Bendavid E. The cost-effectiveness of preexposure prophylaxis for HIV prevention in the United States in men who have sex with men. Ann Intern Med 2012; 156 541–50.
| The cost-effectiveness of preexposure prophylaxis for HIV prevention in the United States in men who have sex with men.Crossref | GoogleScholarGoogle Scholar | 22508731PubMed |
[54] Law MG, Prestage G, Grulich A, Van de Ven P, Kippax S. Modelling the effect of combination antiretroviral treatments on HIV incidence. AIDS 2001; 15 1287–94.
| Modelling the effect of combination antiretroviral treatments on HIV incidence.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD3MzmsVygtw%3D%3D&md5=b6425fb69b957785e1a43e969ccf3fd9CAS | 11426074PubMed |
[55] Gomez GB, Borquez A, Cáceres CF, Segura ER, Grant RM, Garnett GP, et al The potential impact of pre-exposure prophylaxis for HIV prevention among men who have sex with men and transwomen in Lima, Peru: a mathematical modelling study. PLoS Med 2012; 9 e1001323
| The potential impact of pre-exposure prophylaxis for HIV prevention among men who have sex with men and transwomen in Lima, Peru: a mathematical modelling study.Crossref | GoogleScholarGoogle Scholar | 23055836PubMed |
[56] Gardner EM, McLees MP, Steiner JF, del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis 2011; 52 793–800.
| The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection.Crossref | GoogleScholarGoogle Scholar | 21367734PubMed |
[57] Gomez GB, Borquez A, Case KK, Wheelock A, Vassall A, Hankins C. The cost and impact of scaling up pre-exposure prophylaxis for HIV prevention: a systematic review of cost-effectiveness modelling studies. PLoS Med 2013; 10 e1001401
| The cost and impact of scaling up pre-exposure prophylaxis for HIV prevention: a systematic review of cost-effectiveness modelling studies.Crossref | GoogleScholarGoogle Scholar | 23554579PubMed |
[58] Cohen MS, Gay CL. Treatment to prevent transmission of HIV-1. Clin Infect Dis 2010; 50 S85–95.
| Treatment to prevent transmission of HIV-1.Crossref | GoogleScholarGoogle Scholar | 20397961PubMed |
[59] Dodd PJ, Garnett GP, Hallett TB. Examining the promise of HIV elimination by ‘test and treat’ in hyperendemic settings. AIDS 2010; 24 729–35.
| Examining the promise of HIV elimination by ‘test and treat’ in hyperendemic settings.Crossref | GoogleScholarGoogle Scholar | 20154580PubMed |
[60] Das M, Chu PL, Santos GM, Scheer S, Vittinghoff E, McFarland W, et al Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS ONE 2010; 5 e11068
| Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco.Crossref | GoogleScholarGoogle Scholar | 20548786PubMed |
[61] Katz MH, Schwarcz SK, Kellogg TA, Klausner JD, Dilley JW, Gibson S, et al Impact of highly active antiretroviral treatment on HIV seroincidence among men who have sex with men: San Francisco. Am J Public Health 2002; 92 388–94.
| Impact of highly active antiretroviral treatment on HIV seroincidence among men who have sex with men: San Francisco.Crossref | GoogleScholarGoogle Scholar | 11867317PubMed |
[62] Raymond HF, Chen YH, Ick T, Scheer S, Bernstein K, Liska S, et al A new trend in the HIV epidemic among men who have sex with men, San Francisco, 2004–2011. J Acquir Immune Defic Syndr 2013; 62 584–9.
| A new trend in the HIV epidemic among men who have sex with men, San Francisco, 2004–2011.Crossref | GoogleScholarGoogle Scholar | 23334505PubMed |
[63] San Francisco Department of Public Health (SFDPH). HIV epidemiology annual report 2012. San Francisco: SFDPH, HIV Epidemiology Section; 2013 Available online at: http://www.sfdph.org/dph/files/reports/RptsHIVAIDS/AnnualReport2012.pdf [verified 2013 September ].
[64] Cowan SA, Gerstoft J, Haff J, Christiansen AH, Nielsen J, Obel N. Stable incidence of HIV diagnoses among Danish MSM despite increased engagement in unsafe sex. J Acquir Immune Defic Syndr 2012; 61 106–11.
| Stable incidence of HIV diagnoses among Danish MSM despite increased engagement in unsafe sex.Crossref | GoogleScholarGoogle Scholar | 22592584PubMed |
[65] Birrell PJ, Gill ON, Delpech VC, Brown AE, Desai S, Chadborn TR, et al HIV incidence in men who have sex with men in England and Wales 2001–10: a nationwide population study. Lancet Infect Dis 2013; 13 313–8.
| HIV incidence in men who have sex with men in England and Wales 2001–10: a nationwide population study.Crossref | GoogleScholarGoogle Scholar | 23375420PubMed |
[66] Phillips AN, Cambiano V, Nakagawa F, Brown AE, Lampe F, Rodger A, et al Increased HIV incidence in men who have sex with men despite high levels of ART-induced viral suppression: analysis of an extensively documented epidemic. PLoS ONE 2013; 8 e55312
| Increased HIV incidence in men who have sex with men despite high levels of ART-induced viral suppression: analysis of an extensively documented epidemic.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3sXjsVakur8%3D&md5=f49f16733f2e8d51842c30617fd0cb31CAS | 23457467PubMed |
[67] Bezemer D, de Wolf F, Boerlijst MC, van Sighem A, Hollingsworth TD, Prins M, et al A resurgent HIV-1 epidemic among men who have sex with men in the era of potent antiretroviral therapy. AIDS 2008; 22 1071–7.
| A resurgent HIV-1 epidemic among men who have sex with men in the era of potent antiretroviral therapy.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD1cXmsFyls7w%3D&md5=df66c76a7df9b7b6717ae1d517281c7cCAS | 1:CAS:528:DC%2BD1cXmsFyls7w%3D&md5=df66c76a7df9b7b6717ae1d517281c7cCAS | 18520351PubMed |
[68] Bezemer D, de Wolf F, Boerlijst MC, van Sighem A, Hollingsworth TD, Fraser C. 27 years of the HIV epidemic amongst men having sex with men in the Netherlands: an in depth mathematical model-based analysis. Epidemics 2010; 2 66–79.
| 27 years of the HIV epidemic amongst men having sex with men in the Netherlands: an in depth mathematical model-based analysis.Crossref | GoogleScholarGoogle Scholar | 21352777PubMed |
[69] van Sighem A, Jansen I, Bezemer D, de Wolf F, Prins M, Stolte I, et al Increasing sexual risk behaviour among Dutch men who have sex with men: mathematical models versus prospective cohort data. AIDS 2012; 26 1840–3.
| Increasing sexual risk behaviour among Dutch men who have sex with men: mathematical models versus prospective cohort data.Crossref | GoogleScholarGoogle Scholar | 22781219PubMed |
[70] van Sighem A, Vidondo B, Glass TR, Bucher HC, Vernazza P, Gebhardt M, et al Resurgence of HIV infection among men who have sex with men in Switzerland: mathematical modelling study. PLoS ONE 2012; 7 e44819
| Resurgence of HIV infection among men who have sex with men in Switzerland: mathematical modelling study.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC38XhsVSjtbbN&md5=5e93b706ec024f34735ba439999fc163CAS | 1:CAS:528:DC%2BC38XhsVSjtbbN&md5=5e93b706ec024f34735ba439999fc163CAS | 23024766PubMed |
[71] Cohen MS, Muessig KE, Smith MK, Powers KA, Kashuba AD. Antiviral agents and HIV prevention: controversies, conflicts, and consensus. AIDS 2012; 26 1585–98.
| Antiviral agents and HIV prevention: controversies, conflicts, and consensus.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC38XhtFOru7rK&md5=009bec57bca68e57765274379c0d4cacCAS | 1:CAS:528:DC%2BC38XhtFOru7rK&md5=009bec57bca68e57765274379c0d4cacCAS | 22507927PubMed |
[72] Wilson DP. HIV treatment as prevention: natural experiments highlight limits of antiretroviral treatment as HIV prevention. PLoS Med 2012; 9 e1001231
| HIV treatment as prevention: natural experiments highlight limits of antiretroviral treatment as HIV prevention.Crossref | GoogleScholarGoogle Scholar | 22807656PubMed |
[73] Zablotska IB, Kippax S, Grulich A, Holt M, Prestage G. Behavioural surveillance among gay men in Australia: methods, findings and policy implications for the prevention of HIV and other sexually transmissible infections. Sex Health 2011; 8 272–9.
| Behavioural surveillance among gay men in Australia: methods, findings and policy implications for the prevention of HIV and other sexually transmissible infections.Crossref | GoogleScholarGoogle Scholar | 21851766PubMed |
[74] De Wit J, Mao L, Treloar C, eds. HIV/AIDS, hepatitis and sexually transmissible infections in Australia: annual report of trends in behaviour 2013. Sydney: Centre for Social Research in Health, University of New South Wales; 2013.
[75] Law MG, Woolley I, Templeton DJ, Roth N, Chuah J, Mulhall B, et al Trends in detectable viral load by calendar year in the Australian HIV observational database. J Int AIDS Soc 2011; 14 10
| Trends in detectable viral load by calendar year in the Australian HIV observational database.Crossref | GoogleScholarGoogle Scholar | 21345234PubMed |
[76] Wand H, Wilson D, Yan P, Gonnermann A, McDonald A, Kaldor J, et al Characterizing trends in HIV infection among men who have sex with men in Australia by birth cohorts: results from a modified back-projection method. J Int AIDS Soc 2009; 12 19
| Characterizing trends in HIV infection among men who have sex with men in Australia by birth cohorts: results from a modified back-projection method.Crossref | GoogleScholarGoogle Scholar | 19761622PubMed |
[77] Jin F, Jansson J, Law M, Prestage GP, Zablotska I, Imrie JC, et al Per-contact probability of HIV transmission in homosexual men in Sydney in the era of HAART. AIDS 2010; 24 907–13.
| Per-contact probability of HIV transmission in homosexual men in Sydney in the era of HAART.Crossref | GoogleScholarGoogle Scholar | 20139750PubMed |
[78] Cassell MM, Halperin DT, Shelton JD, Stanton D. Risk compensation: the Achilles’ heel of innovations in HIV prevention? BMJ 2006; 332 605–7.
| Risk compensation: the Achilles’ heel of innovations in HIV prevention?Crossref | GoogleScholarGoogle Scholar | 16528088PubMed |
[79] Eaton LA, Kalichman S. Risk compensation in HIV prevention: implications for vaccines, microbicides, and other biomedical HIV prevention technologies. Curr HIV/AIDS Rep 2007; 4 165–72.
| Risk compensation in HIV prevention: implications for vaccines, microbicides, and other biomedical HIV prevention technologies.Crossref | GoogleScholarGoogle Scholar | 18366947PubMed |
[80] Liu AY, Vittinghoff E, Chillag K, Mayer K, Thompson M, Grohskopf L, et al Sexual risk behavior among HIV-uninfected men who have sex with men participating in a tenofovir preexposure prophylaxis randomized trial in the United States. J Acquir Immune Defic Syndr 2013; 64 87–94.
| Sexual risk behavior among HIV-uninfected men who have sex with men participating in a tenofovir preexposure prophylaxis randomized trial in the United States.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3sXht12jtLrN&md5=aa50cf621c4a396fb9accd0060aaf9beCAS | 1:CAS:528:DC%2BC3sXht12jtLrN&md5=aa50cf621c4a396fb9accd0060aaf9beCAS | 23481668PubMed |
[81] Baeten J, Celum C. Oral antiretroviral chemoprophylaxis: current status. Curr Opin HIV AIDS 2012; 7 514–9.
| Oral antiretroviral chemoprophylaxis: current status.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3sXis1Wlsrk%3D&md5=5c2a061c6b773d7757163953ae62a374CAS | 1:CAS:528:DC%2BC3sXis1Wlsrk%3D&md5=5c2a061c6b773d7757163953ae62a374CAS | 22964886PubMed |
[82] Golub SA, Kowalczyk W, Weinberger CL, Parsons JT. Preexposure prophylaxis and predicted condom use among high-risk men who have sex with men. J Acquir Immune Defic Syndr 2010; 54 548–55.
| Preexposure prophylaxis and predicted condom use among high-risk men who have sex with men.Crossref | GoogleScholarGoogle Scholar | 20512046PubMed |
[83] Holt M, Murphy DA, Callander D, Ellard J, Rosengarten M, Kippax SC, et al Willingness to use HIV pre-exposure prophylaxis and the likelihood of decreased condom use are both associated with unprotected anal intercourse and the perceived likelihood of becoming HIV positive among Australian gay and bisexual men. Sex Transm Infect 2012; 88 258–63.
| Willingness to use HIV pre-exposure prophylaxis and the likelihood of decreased condom use are both associated with unprotected anal intercourse and the perceived likelihood of becoming HIV positive among Australian gay and bisexual men.Crossref | GoogleScholarGoogle Scholar | 22290327PubMed |
[84] Crepaz N, Hart TA, Marks G. Highly active antiretroviral therapy and sexual risk behavior: a meta-analytic review. JAMA 2004; 292 224–36.
| Highly active antiretroviral therapy and sexual risk behavior: a meta-analytic review.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD2cXlvVSmsL8%3D&md5=c2aa3a6deefa6f5b2509c4df241c759cCAS | 1:CAS:528:DC%2BD2cXlvVSmsL8%3D&md5=c2aa3a6deefa6f5b2509c4df241c759cCAS | 15249572PubMed |
[85] Stolte IG, de Wit JBF, van Eeden A, Coutinho RA, Dukers NH. Perceived viral load, but not actual HIV-1-RNA load, is associated with sexual risk behaviour among HIV-infected homosexual men. AIDS 2004; 18 1943–9.
| Perceived viral load, but not actual HIV-1-RNA load, is associated with sexual risk behaviour among HIV-infected homosexual men.Crossref | GoogleScholarGoogle Scholar | 15353980PubMed |
[86] Stolte IG, Dukers NH, Geskus RB, Coutinho RA, de Wit JBF. Homosexual men change to risky sex when perceiving less threat of HIV/AIDS since availability of highly active antiretroviral therapy: a longitudinal study. AIDS 2004; 18 303–9.
| Homosexual men change to risky sex when perceiving less threat of HIV/AIDS since availability of highly active antiretroviral therapy: a longitudinal study.Crossref | GoogleScholarGoogle Scholar | 15075549PubMed |
[87] van der Snoek EM, de Wit JBF, Mulder PG, van der Meijden WI. Incidence of sexually transmitted diseases and HIV infection related to perceived HIV/AIDS threat since highly active antiretroviral therapy availability in men who have sex with men. Sex Transm Dis 2005; 32 170–5.
| Incidence of sexually transmitted diseases and HIV infection related to perceived HIV/AIDS threat since highly active antiretroviral therapy availability in men who have sex with men.Crossref | GoogleScholarGoogle Scholar | 15729154PubMed |
[88] Dukers NH, Goudsmit J, de Wit JBF, Prins M, Weverling GJ, Coutinho RA. Sexual risk behaviour relates to the virological and immunological improvements during highly active antiretroviral therapy in HIV-1 infection. AIDS 2001; 15 369–78.
| Sexual risk behaviour relates to the virological and immunological improvements during highly active antiretroviral therapy in HIV-1 infection.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD3M7ntlWgsA%3D%3D&md5=a6e4ed3bb51407fd7a115534e3612828CAS | 1:STN:280:DC%2BD3M7ntlWgsA%3D%3D&md5=a6e4ed3bb51407fd7a115534e3612828CAS | 11273217PubMed |
[89] Jansen IA, Geskus RB, Davidovich U, Jurriaans S, Coutinho RA, Prins M, et al Ongoing HIV-1 transmission among men who have sex with men in Amsterdam: a 25-year prospective cohort study. AIDS 2011; 25 493–501.
| Ongoing HIV-1 transmission among men who have sex with men in Amsterdam: a 25-year prospective cohort study.Crossref | GoogleScholarGoogle Scholar | 21192230PubMed |
[90] Stolte IG, Dukers NH, de Wit JB, Fennema JS, Coutinho RA. Increase in sexually transmitted infections among homosexual men in Amsterdam in relation to HAART. Sex Transm Infect 2001; 77 184–6.
| Increase in sexually transmitted infections among homosexual men in Amsterdam in relation to HAART.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD3MzmsFylug%3D%3D&md5=cb8788857a7607e6efc17536c5554921CAS | 1:STN:280:DC%2BD3MzmsFylug%3D%3D&md5=cb8788857a7607e6efc17536c5554921CAS | 11402225PubMed |
[91] Hasse B, Ledergerber B, Hirschel B, Vernazza P, Glass TR, Jeannin AE, et al Frequency and determinants of unprotected sex among HIV-infected persons: the Swiss HIV cohort study. Clin Infect Dis 2010; 51 1314–22.
| Frequency and determinants of unprotected sex among HIV-infected persons: the Swiss HIV cohort study.Crossref | GoogleScholarGoogle Scholar | 21034200PubMed |
[92] Kurth AE, Celum C, Baeten JM, Vermund SH, Wasserheit JN. Combination HIV prevention: significance, challenges, and opportunities. Curr HIV/AIDS Rep 2011; 8 62–72.
| Combination HIV prevention: significance, challenges, and opportunities.Crossref | GoogleScholarGoogle Scholar | 20941553PubMed |
[93] Celum C, Baeten JM, Hughes JP, Barnabas R, Liu A, Van Rooyen H, et al Integrated strategies for combination HIV prevention: principles and examples for men who have sex with men in the Americas and heterosexual African populations. J Acquir Immune Defic Syndr 2013; 63 S213–20.
| Integrated strategies for combination HIV prevention: principles and examples for men who have sex with men in the Americas and heterosexual African populations.Crossref | GoogleScholarGoogle Scholar | 23764638PubMed |
[94] Glasgow RE, Eckstein ET, Elzarrad MK. Implementation science perspectives and opportunities for HIV/AIDS research: integrating science, practice, and policy. J Acquir Immune Defic Syndr 2013; 63 S26–31.
| Implementation science perspectives and opportunities for HIV/AIDS research: integrating science, practice, and policy.Crossref | GoogleScholarGoogle Scholar | 23673882PubMed |
[95] Schackman BR, Eggman AA. Cost-effectiveness of pre-exposure prophylaxis for HIV: a review. Curr Opin HIV AIDS 2012; 7 587–92.
| Cost-effectiveness of pre-exposure prophylaxis for HIV: a review.Crossref | GoogleScholarGoogle Scholar | 23076124PubMed |
[96] Coates TJ, Richter L, Cáceres C. Behavioural strategies to reduce HIV transmission: how to make them work better. Lancet 2008; 372 669–84.
| Behavioural strategies to reduce HIV transmission: how to make them work better.Crossref | GoogleScholarGoogle Scholar | 18687459PubMed |
[97] Amico KR. The key role of adherence for the effectiveness of antiretroviral-based prevention: state of the science and implications for Asia Pacific. Sex Health 2014; 11 155–65.
| The key role of adherence for the effectiveness of antiretroviral-based prevention: state of the science and implications for Asia Pacific.Crossref | GoogleScholarGoogle Scholar | 24331438PubMed |
[98] Coates TJ. An expanded behavioral paradigm for prevention and treatment of HIV-1 infection. J Acquir Immune Defic Syndr 2013; 63 S179–82.
| An expanded behavioral paradigm for prevention and treatment of HIV-1 infection.Crossref | GoogleScholarGoogle Scholar | 23764633PubMed |
[99] Mao L, de Wit J, Adam P, Post JJ, Crooks L, Kidd MR, et al Australian prescribers’ perspectives on ART initiation in the era of “treatment as prevention”. AIDS Care 2013;
| Australian prescribers’ perspectives on ART initiation in the era of “treatment as prevention”.Crossref | GoogleScholarGoogle Scholar | 23406458PubMed |
[100] Sullivan PS, Grey JA, Rosser BRS. Emerging technologies for HIV prevention for MSM: what we have learned, and ways forward. J Acquir Immune Defic Syndr 2013; 63 S102–7.
| Emerging technologies for HIV prevention for MSM: what we have learned, and ways forward.Crossref | GoogleScholarGoogle Scholar | 23673879PubMed |
[101] De Wit JBF, Adam PCG. HIV/AIDS: the role of behavior and the social environment in a global pandemic. In Ramachandran, V., editor. Encyclopedia of human behavior. 2nd edn. Amsterdam: Elsevier; 2012. pp. 316–323.
[102] Cáceres CF, Aggleton P, Galea JT. Sexual diversity, social inclusion and HIV/AIDS. AIDS 2008; 22 S45–55.
| Sexual diversity, social inclusion and HIV/AIDS.Crossref | GoogleScholarGoogle Scholar | 18641469PubMed |
[103] Buchbinder SP, Liu A. Pre-exposure prophylaxis and the promise of combination prevention approaches. AIDS Behav 2011; 15 S72–9.
| Pre-exposure prophylaxis and the promise of combination prevention approaches.Crossref | GoogleScholarGoogle Scholar | 21331801PubMed |
